Soros Fund Management’s American Oncology Network, Inc. Warrant AONCW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-125,000
Closed -$7.5K 237
2022
Q4
$7.5K Hold
125,000
﹤0.01% 200
2022
Q3
$9K Hold
125,000
﹤0.01% 227
2022
Q2
$34K Hold
125,000
﹤0.01% 214
2022
Q1
$50K Hold
125,000
﹤0.01% 217
2021
Q4
$82K Hold
125,000
﹤0.01% 227
2021
Q3
$86K Hold
125,000
﹤0.01% 221
2021
Q2
$117K Buy
+125,000
New +$99.8K ﹤0.01% 242

Other funds holding AONCW

Soros Fund Management's AONCW Position: Q1 2023 in Review

Soros Fund Management sold out of American Oncology Network, Inc. Warrant (AONCW) in Q1 2023, closing a stake of 125,000 shares — an estimated $7.5K sold.

Soros Fund Management first reported a position in AONCW in Q2 2021 and held it in 7 quarters. The position peaked at $117K in Q2 2021. 50 funds tracked by Wall St. Rank hold AONCW as of Q1 2023.

  • Soros Fund Management reported no remaining American Oncology Network, Inc. Warrant position as of Q1 2023 after selling out during the quarter.
  • Soros Fund Management sold 125,000 American Oncology Network, Inc. Warrant shares in Q1 2023, an estimated $7.5K.
  • Soros Fund Management first reported a position in American Oncology Network, Inc. Warrant in Q2 2021 and held it in 7 quarters.
  • Soros Fund Management's American Oncology Network, Inc. Warrant position peaked at $117K in Q2 2021.
  • 50 funds tracked by Wall St. Rank held American Oncology Network, Inc. Warrant as of Q1 2023.

Based on Soros Fund Management's 13F filing for Q1 2023, filed 12 May 2023.